01 1RANKE QUIMICA, SA
02 1RANKE QUIMICA, SA (ALMIRALL PRODESFARMA CHEMICAL PLANT)
01 2Yuhan Corporation
01 2Almotriptan
01 2Spain
Registrant Name : Yuhan Corporation
Registration Date : 2007-03-28
Registration Number : 22-2-ND
Manufacturer Name : RANKE QUIMICA, SA
Manufacturer Address : Ctra. de Martorell 41-61 08740 SANT ANDREU DE LA BARCA (BARCELONA)
Registrant Name : Yuhan Corporation
Registration Date : 2011-06-15
Registration Number : 22-8-ND
Manufacturer Name : RANKE QUIMICA, SA (ALMIRALL ...
Manufacturer Address : Ctra. Granollers-Girona (C-35), Km 58.85 08470 Sant Celoni, Barcelona-Spain
A Almotriptan manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Almotriptan, including repackagers and relabelers. The FDA regulates Almotriptan manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Almotriptan API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Almotriptan manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Almotriptan supplier is an individual or a company that provides Almotriptan active pharmaceutical ingredient (API) or Almotriptan finished formulations upon request. The Almotriptan suppliers may include Almotriptan API manufacturers, exporters, distributors and traders.
click here to find a list of Almotriptan suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Almotriptan Drug Master File in Korea (Almotriptan KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Almotriptan. The MFDS reviews the Almotriptan KDMF as part of the drug registration process and uses the information provided in the Almotriptan KDMF to evaluate the safety and efficacy of the drug.
After submitting a Almotriptan KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Almotriptan API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Almotriptan suppliers with KDMF on PharmaCompass.
LOOKING FOR A SUPPLIER?
